Encouraging interest in STEM is one of our top goals at the Fogarty Institute. And that starts with offering opportunities, which is why Fogarty has partnered with the Boys & Girls Clubs of the Peninsula (BGCP) to show them the fields of medtech and entrepreneurship firsthand. For example, next summer, we will be offering the chance for BGCP college students to join the Lefteroff internship program.
If there was one “most valuable player” that everyone in medical settings relied on during the pandemic, many would name personal protective equipment (PPE). However, while the lack of proper equipment has been felt acutely in every facility, the problem is not yet solved six months into COVID-19, with experts predicting that shortages could persist for years to come.
COVID-19 might have temporarily closed dentist offices, but that hasn’t stopped iDentical from raising a healthy amount of cash for its innovative alternative to traditional dental implants.
Fogarty Institute company-in-residence iDentical has developed drill-free, non-invasive dental implants that leverage the latest 3D technology, with the goal of making tooth replacement safer,
If there’s one thing that incubators know how to do, it’s innovate. Therefore, it should come as no surprise that while the global pandemic provided challenges for everyone in every industry, incubators were able to find creative ways to survive and thrive.
A recent panel presentation brought together a number of speakers associated with all aspects of the incubator ecosystem,
To effectively introduce a new product to market and ensure it is widely adopted, medtech companies must consider the many facets of their go-to-market strategy from the earliest days of product development.
This was the message of the Fogarty Institute’s third-annual educational workshop focused on commercialization. The three-part seminar series, being presented virtually to adhere to COVID restrictions,
A former Stanford Biodesign Fellow and Fogarty Institute entrepreneur, 32-year-old Holly Rockweiler has already had remarkable accomplishments early in her career, fluently moving her startup to the next level.
Most notably, Holly has parlayed Madorra’s impressive study results into securing funding, including winning several pitching competitions, despite the chronically challenging medtech fundraising environment.
Each year, the caliber of professionals who participate in the Ferolyn Fellowship continues to impress us. Hailing from diverse parts of the healthcare spectrum, they all share an undeniable passion for the medtech industry, coupled with curiosity and the tenacity to solve large problems. In addition, it’s clear that they desire to be part of a community committed to not only accelerating their own career path,
Fogarty Institute graduate InterVene, a startup that has developed a minimally invasive device for the treatment of venous disease in the legs, has treated the 10th patient in their ongoing, multi-center, feasibility study in New Zealand and Australia.
Learning to build a healthy company culture; becoming an empathetic, yet effective, leader; and giving back to individuals and the industry are just a few of the important skill sets learned by the Ferolyn Fellows. They are also key traits embodied by the program’s namesake, Ferolyn Powell.
When a cardiovascular intervention is called for, a less-invasive solution is always preferred – which is why percutaneous procedures, such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR) are on the rise.
But this trend hasn’t been without its drawbacks, as cardiologists and surgeons are now faced with the challenge of closing relatively large femoral access sites – ranging from three to eight millimeters in size – that are required to conduct these procedures.